Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Data Validation01:15

Data Validation

141
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
141

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fiducial-Based Statistical Intervals for Bounded Bioanalytical Data Using the Kumaraswamy Distribution.

Pharmaceutical statistics·2026
Same author

High-Dose Subcutaneous Administration of Biologics: Overcoming Barriers Through Formulation and Device Innovation.

Advanced drug delivery reviews·2026
Same author

Application of Analytical Measurement Uncertainty and Considerations toward Pharmaceutical Material Quality Control Strategies.

Analytical chemistry·2025
Same author

Implementation of a high throughput automated platform for residual DNA quantitation.

PloS one·2025
Same author

Enzymatic Desialylation Enables Reliable Charge Variant Characterization of Highly Glycosylated and Sialylated Fc Fusion Proteins.

ACS pharmacology & translational science·2025
Same author

Neuromuscular transmission deficits in patients with CMT and ClC-1 inhibition in CMT animal models.

Annals of clinical and translational neurology·2024

Related Experiment Video

Updated: May 27, 2025

Home-Based Monitor for Gait and Activity Analysis
07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

6.7K

Achieving Acceleration to First-in-Human: MSD's Learnings on Platform Method Validation Strategy.

Xiaoqing Hua1, Jorge Quiroz2, Joop Waterval1

  • 1Analytical Research & Development, MSD, Rahway, NJ, USA.

Mabs
|February 18, 2025
PubMed
Summary

MSD developed a platform analytical method validation approach to accelerate early-stage drug development. This strategy reduces validation timelines from 4 months to 1-2 months, enabling faster first-in-human trials.

Keywords:
Platform validationacceleration to FIHstatistical analyses

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.5K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K

Related Experiment Videos

Last Updated: May 27, 2025

Home-Based Monitor for Gait and Activity Analysis
07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

6.7K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.5K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K

Area of Science:

  • Biopharmaceutical Development
  • Analytical Chemistry
  • Regulatory Science

Background:

  • The number of therapeutic protein pipelines has surged, necessitating accelerated early-stage development for novel therapies.
  • Fast first-in-human (FIH) trials are crucial for bringing innovative treatments to patients promptly.
  • Existing analytical method validation processes can be time-consuming, potentially delaying clinical progression.

Purpose of the Study:

  • To describe a platform analytical method validation approach implemented by MSD for first-in-human (FIH) programs.
  • To demonstrate how historical data and statistical analyses can support limited validation for new pipeline projects.
  • To showcase the efficiency gains and successful implementation of this strategy in FIH filings.

Main Methods:

  • Summarizing historical validation data within the same therapeutic protein modality.
  • Applying statistical analyses to historical data to support limited validation for future projects.
  • Utilizing a polysorbate 80 (PS-80) platform method as a case study for the workflow.

Main Results:

  • The platform analytical method validation strategy significantly reduced the overall validation timeline from up to 4 months to 1-2 months.
  • This approach has been successfully implemented in multiple FIH filings.
  • The strategy streamlines the validation process without compromising scientific rigor.

Conclusions:

  • Platform analytical method validation offers a viable strategy to accelerate early-phase biopharmaceutical development.
  • This approach enables faster progression to first-in-human trials, benefiting patients awaiting novel therapies.
  • Pharmaceutical companies can leverage this strategy to optimize their development timelines and regulatory submissions.